Factor VIII/von Willebrand factor concentrate therapy for ventricular assist device-associated acquired von Willebrand disease

Transfusion

Volumn 52, Issue 7, 2012, Pages 1535-1541

  Cushing, Melissa ^a,b   Kawaguchi, Kathy ^a,b   Friedman, Kenneth D ^a,b   Mark, Tomer ^a,b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; AMIODARONE; BLOOD CLOTTING FACTOR 8 CONCENTRATE; HEPARIN; MILRINONE; VON WILLEBRAND FACTOR;

ADULT; AORTA VALVE REGURGITATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD CLOTTING; BLOOD SAMPLING; CASE REPORT; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; ERYTHROCYTE TRANSFUSION; HEART AMYLOIDOSIS; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HEMOSTASIS; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; MALE; MITRAL VALVE REGURGITATION; MULTIPLE MYELOMA; PATIENT MONITORING; PROTHROMBIN TIME; RIGHT VENTRICULAR ASSIST DEVICE; RISK FACTOR; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

FACTOR VIII; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PACEMAKER, ARTIFICIAL; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 84863787955     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03500.x     Document Type: Article

References (16)

1. Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A, Jude B,. Acquired von Willebrand syndrome in aortic senosis. N Engl J Med 2003; 349: 343-9.
2. Tsai HM, Sussman I, Nagel RL,. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood 1994; 83: 2171-9.
3. Malehsa D, Meyer A, Bara C, Strüber M,. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Eur J Cardiothorac Surg 2009; 35: 1091-3.
4. Geisen U, Heilmann C, Beyersdorf F, Benk C, Berchtold-Herz M, Schlensak C, Budde U, Zieger B,. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 2008; 33: 679-84.
5. Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB,. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol 2009; 53: 2162-7.
6. Dong JF,. Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions. J Thromb Haemost 2005; 3: 1710-6.
7. Crow S, Chen D, Milano C, Thomas W, Joyce L, Piacentino V 3rd, Sharma R, Wu J, Arepally G, Bowles D, Rogers J, Villamizar-Ortiz N,. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg 2010; 90: 1263-9.
8. Uriel N, Pak SW, Jorde UP,. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 2010; 56: 1207-13.
9. Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A, Strueber M,. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 2010; 3: 675-81.
10. Karkouti K, Beattie WS, Dattilo KM, McCluskey SA, Ghannam M, Hamdy A, Wijeysundera DN, Fedorko L, Yau TM,. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 2006; 46: 327-38.
11. Auerswald G, Kreuz W,. Haemate P/Humate-P for the treatment of von Willebrand disease: considerations for use and clinical experience. Haemophilia 2008; 14: 39-46.
12. Metzner HJ, Hermentin P, Cuesta-Linker T, Langner S, Muller HG, Friedbold J,. Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis. Hemophilia 1998; 4: 25-32.
13. Montgomery RR, Hathaway WE, Johnson J, Jacobson L, Muntean W,. A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity. Blood 1982; 60: 201-7.
14. Andreas T, Rand J, Budde U, Ganser A, Federici AB,. How I treat acquired von Willebrand syndrome. Blood 2011; 117: 6777-85.
15. Crow S, Milano C, Joyce L, Chen D, Arepally G, Bowles D, Thomas W, Ortiz NV,. Comparative analysis of von Willebrand factor profiles in pulsatile and continuous left ventricular assistant device recipients. ASAIO J 2010; 56: 441-5.
16. Richard C, Cuadrado MA, Prieto M, Batlle J, Lopez Fernandez MT, Rodriguez Salazar MC, Bello C, Recio M, Santoro T, Gomez Casares MT,. Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells. Am J Hematol 1990; 35: 114-7.